1
|
Hanafiah A, Razak SA, Neoh HM, Zin NM, Lopes BS. The heterogeneic distribution of Helicobacter pylori cag pathogenicity island reflects different pathologies in multiracial Malaysian population. Braz J Infect Dis 2020; 24:545-551. [PMID: 33157035 PMCID: PMC9392095 DOI: 10.1016/j.bjid.2020.10.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/28/2020] [Revised: 09/29/2020] [Accepted: 10/22/2020] [Indexed: 02/07/2023] Open
Abstract
Background Results Conclusions
Collapse
|
2
|
Shim HI, Song DJ, Shin CM, Yoon H, Park YS, Kim N, Lee DH. [Inhibitory Effects of β-caryophyllene on Helicobacter pylori Infection: A Randomized Double-blind, Placebo-controlled Study]. THE KOREAN JOURNAL OF GASTROENTEROLOGY 2020; 74:199-204. [PMID: 31650795 DOI: 10.4166/kjg.2019.74.4.199] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/13/2019] [Revised: 06/07/2019] [Accepted: 07/31/2019] [Indexed: 12/23/2022]
Abstract
Background/Aims Helicobacter pylori (H. pylori) infections, which cause a variety of gastrointestinal symptoms, are common in South Korea. Recent reports have shown a decline in the H. pylori eradication rates. β-caryophyllene is a natural bicyclic sesquiterpene that occurs in a wide range of plant species, such as cloves, basil, and cinnamon. β-caryophyllene has been reported to have anti-inflammatory and anti-bacterial effects. This study investigated the inhibitory effects of β-caryophyllene on H. pylori and its potential role as an alternative gastrointestinal drug. Methods This 8-week, randomized double-blind, placebo-controlled trial categorized subjects into a β-caryophyllene group (33 patients who received 126 mg/day of β-caryophyllene) and a placebo group (33 patients who received a placebo preparation). The inflammation level of H. pylori infiltration and the eradication rates were evaluated endoscopically and with the urea breath test (UBT) in both groups before and after administering the medication. The serum cytokine levels (tumor necrosis factor-α, and interleukin [IL]-1β and IL-6) were compared in both groups before and after administering the medication. Results Complete eradication was not observed in either group. Moreover, there was no significant change in the UBT and updated Sydney score. On the other hand, the β-caryophyllene group showed significant improvement in nausea (p=0.025) and epigastric pain (p=0.018), as well as a decrease in the serum IL-1β levels (p=0.038). Conclusions β-caryophyllene improves dyspepsia symptoms and can be considered a useful supplementary treatment for gastrointestinal disease.
Collapse
Affiliation(s)
- Hyun Ik Shim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Dong Jin Song
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Cheol Min Shin
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Hyuk Yoon
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Young Soo Park
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea
| | - Nayoung Kim
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.,Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
| | - Dong Ho Lee
- Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea.,Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea
| |
Collapse
|
3
|
Liutu M, Kalimo K, Leino R, Uksila J, Kalimo H. Chronic urticaria andHelicobacter pyloriinfection. J DERMATOL TREAT 2009. [DOI: 10.3109/09546639809160686] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022]
|
4
|
Chu KM, Kwok KF, Law S, Wong KH. Patients with Helicobacter pylori positive and negative duodenal ulcers have distinct clinical characteristics. World J Gastroenterol 2005; 11:3518-22. [PMID: 15962366 PMCID: PMC4315952 DOI: 10.3748/wjg.v11.i23.3518] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/06/2023] Open
Abstract
AIM: To assess the clinical characteristics of Helicobacter pylori (H pylori) negative duodenal ulcer.
METHODS: Patients with an endoscopic diagnosis of duodenal ulcer between 1996 and 2002 were included in the present study. Patients were considered to be negative for H pylori, if both histological examination and rapid urease test of biopsy specimens were negative. A comparison was made between patients with H pylori positive and negative duodenal ulcers.
RESULTS: A total of 1 343 patients were studied. Their mean age was 54.7±0.5 years. There was a male preponderance (M:F = 2.5:1). Three hundred and ninety-eight patients (29.6%) did not have H pylori infection. The annual proportion of patients with H pylori negative duodenal ulcers increased progressively from 1996 to 2002. On multivariate analysis, patients with H pylori negative duodenal ulcer were more likely to be older, have concomitant medical problem, pre-existing malignancy, recent surgery, underlying sepsis, or taken non-steroidal anti-inflammatory drugs. In terms of clinical presentations, patients with H pylori negative duodenal ulcer were more likely to present with bleeding, multiple ulcers and larger ulcers.
CONCLUSION: The proportion of patients with H pylori negative duodenal ulcers is on the rise because of a continued drop in incidence of H pylori positive duodenal ulcers in recent years. Such patients have distinct clinical characteristics and it is important to ascertain the H pylori status before starting eradication therapy.
Collapse
Affiliation(s)
- Kent-Man Chu
- Department of Surgery, University of Hong Kong Medical Center, Queen Mary Hospital, Pokfulam, Hong Kong, China.
| | | | | | | |
Collapse
|
5
|
Arakawa T, Higuchi K, Fujiwara Y, Tominaga K, Watanabe T, Shiba M, Oshitani N, Matsumoto T. Has Helicobacter pylori eradication for peptic ulcer been overrated? Intern Med 2004; 43:179-83. [PMID: 15098596 DOI: 10.2169/internalmedicine.43.179] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
Abstract
Discovery of Helicobacter pylori has changed the life cycle of peptic ulcer disease (PUD). However, PUD does not completely disappear after elimination of H. pylori. Some ulcers recur even after successful eradication of H. pylori in non-users of non-steroidal anti-inflammatory drug (NSAID). In addition, the incidence of H. pylori-negative, non-NSAID PUD (idiopathic PUD) is reported to increase with time. Moreover, H. pylori-positive ulcers are not always H. pylori-induced ulcers because there are two paradoxes of the H. pylori myth: the existence of H. pylori-positive non-recurring ulcer and recurring ulcer after cure of H. pylori infection. Taken together, H. pylori is not the only cause of peptic ulcer disease. Therefore, it is still necessary to seriously consider the pathophysiology and the management of the ulcers, which may exist after elimination of H. pylori.
Collapse
Affiliation(s)
- Tetsuo Arakawa
- Department of Gastroenterology, Osaka City University Graduate Medical School, Osaka
| | | | | | | | | | | | | | | |
Collapse
|
6
|
Edwards D. New approaches to brain injury in preterm infants. Dev Neurosci 2003; 24:352-4. [PMID: 12640172 DOI: 10.1159/000069054] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2002] [Accepted: 06/20/2002] [Indexed: 11/19/2022] Open
Abstract
Preterm birth is strongly associated with neurodevelopmental impairment, but the causes of cerebral injury are not completely understood. It is often assumed that damage is due to cerebral hypoxia-ischemia secondary to the extreme stresses induced by prolonged intensive care. However, the primary role of reduced cerebral blood flow is questioned by the findings of several studies that normal cerebral blood flow can be as low as 5–10 ml/100 g<sup>–1</sup>/min<sup>–1</sup> in infants who have normal neurological outcome [1, 2]. Indeed, some commonly used drugs, particularly indomethacin, but also aminophylline, cause significant falls in cerebral blood flow without any clear evidence that they lead to cerebral injury [3, 4].
Collapse
Affiliation(s)
- David Edwards
- Weston Laboratory, Department of Pediatrics, Imperial College Faculty of Medicine, and the Medical Research Council Clinical Sciences Centre, Hammersmith Hospital, London, UK.
| |
Collapse
|
7
|
Lock RA, Coombs GW, McWilliams TM, Pearman JW, Grubb WB, Melrose GJH, Forbes GM. Proteome analysis of highly immunoreactive proteins of Helicobacter pylori. Helicobacter 2002; 7:175-82. [PMID: 12047323 DOI: 10.1046/j.1523-5378.2002.00078.x] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/09/2022]
Abstract
BACKGROUND Identification of the immunoreactive proteins of Helicobacter pylori is important for the development of both diagnostic tests and vaccines relating to the organism. Our aim was to determine whether there are significant differences between human IgG and IgA reactivities to individual H. pylori proteins, and whether patterns of immunoreactivity are sustained across different strains of H. pylori. METHOD The total complement of protein from seven strains of H. pylori was resolved by two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). Proteins were transferred electrophoretically onto polyvinylene difluoride (PVDF) membranes, which were probed with sera pooled either from H. pylori-infected patients, or noninfected (control) patients. Highly immunoreactive proteins were detected using chromogenic enzyme-antibody conjugates recognising either serum IgG or IgA. These proteins were then characterised by tryptic peptide-mass fingerprinting using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS). RESULTS Highly immunoreactive proteins were detected which were common to all seven strains, and recognised by both immunoglobulin subclasses. The proteins appear to be localised in five groups. Protein analysis established that these groups encompass multiple isoforms of chaperonin HspB (two subgroups); urease beta-subunit UreB; elongation factor EF-Tu; and flagellin FlaA. The pattern of highly immunoreactive proteins was strongly conserved across the seven strains. CONCLUSION These results suggest that within a tightly defined region on the H. pylori proteome map there are five groups of proteins that are highly reactive to both IgG and IgA. Our analysis suggests it is unlikely that the highly immunoreactive clusters harbour any significant proteins other than isoforms of HspB, UreB, EF-Tu and FlaA, and that, with the partial exception of FlaA, these clusters are strongly conserved across all seven strains.
Collapse
Affiliation(s)
- Robert A Lock
- Western Australian Proteome Analysis Facility, Western Australian Biomedical Research Institute, Perth, WA, Australia
| | | | | | | | | | | | | |
Collapse
|
8
|
Pakodi F, Abdel-Salam OM, Debreceni A, Mózsik G. Helicobacter pylori. One bacterium and a broad spectrum of human disease! An overview. JOURNAL OF PHYSIOLOGY, PARIS 2000; 94:139-52. [PMID: 10791696 DOI: 10.1016/s0928-4257(00)00160-1] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
Since the historical rediscovery of gastric spiral Helicobacter pylori in the gastric mucosa of patients with chronic gastritis by Warren and Marshall in 1983, peptic ulcer disease has been largely viewed as being of infectious aetiology. Indeed, there is a strong association between the presence of H. pylori and chronic active gastritis in histology. The bacterium can be isolated in not less than 70% of gastric and in over 90% of duodenal ulcer patients. Eradication of the organism has been associated with histologic improvement of gastritis, lower relapse rate and less risk of bleeding from duodenal ulcer. The bacterium possesses several virulence factors enabling it to survive the strong acid milieu inside the stomach and possibly damaging host tissues. The sequence of events by which the bacterium might cause gastric or duodenal ulcer is still not fully elucidated and Koch's postulates have never been fulfilled. In the majority of individuals, H. pylori infection is largely or entirely asymptomatic and there is no convincing data to suggest an increase in the prevalence of peptic ulcer disease among these subjects. An increasingly growing body of literature suggests an association between colonization by H. pylori in the stomach and a risk for developing gastric mucosa-associated lymphoid tissue (MALT), MALT lymphoma, gastric adenocarcinoma and even pancreatic adenocarcinoma. The bacterium has been implicated also in a number of extra-gastrointestinal disorders such as ischaemic heart disease, ischaemic cerebrovascular disease, atherosclerosis, and skin diseases such as rosacea, but a causal role for the bacterium is missing. Eradication of H. pylori thus seems to be a beneficial impact on human health. Various drug regimens are in use to eradicate H. pylori involving the administration of three or four drugs including bismuth compounds, metronidazole, clarithromycin, tetracyclines, amoxycillin, ranitidine, omeprazole for 1-2 weeks. The financial burden, side effects and emergence of drug resistant strains due to an increase in the use in antibiotics for H. pylori eradication therapy need further reconsideration.
Collapse
Affiliation(s)
- F Pakodi
- First Department of Medicine, Medical University of Pécs, Hungary
| | | | | | | |
Collapse
|
9
|
Abstract
Animal models have played a significant role in research that aims to understand peptic ulceration. Firstly, they have helped define basic mechanisms of gastric mucosal defence and repair. The basis for gastric injury following NSAID administration was facilitated by animal models that correlated well with disease in humans. In early studies, ulceration was induced by grossly damaging insults to the gastric mucosa that were unphysiological. With refinement these models provided a clearer appreciation of stress ulceration. The discovery of Helicobacter pylori (H. pylori), as the cause of most ulcers, resulted in a need to re-evaluate the early literature and to look for new models. To date, these have contributed little to our understanding of the pathogenesis of H. pylori-induced ulcer. A major aim of this chapter is to suggest that thorough understanding of the animal models of Helicobacter infection may provide important new insights, in particular the factors controlling gastritis, the essential precursor lesion of ulceration. Available models include primates, cats, guinea pigs, ferrets and pigs. The mouse models provide opportunity for identifying both essential bacterial and host factors. The most severe pathologies are seen in the H. pylori-infected Mongolian gerbil with ulcers being formed in most animals. This is likely to become the standard animal model for investigation of peptic ulcer disease.
Collapse
Affiliation(s)
- A Lee
- School of Microbiology and Immunology, The University of New South Wales, Sydney, Australia
| |
Collapse
|
10
|
Baggot MG. Hypertension muscular/endocameral: a universal idiopathic disorder constituting/causing various arthropathies including those of the universal contractile chamber and their sequelae. Med Hypotheses 1999; 53:333-7. [PMID: 10608269 DOI: 10.1054/mehy.1999.0765] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
The human body is largely composed of similar organs the contractile chambers which are, therefore, prone to similar disorders. Their functions and dysfunctions mainly depend on their constitutent muscles any one of which may overact or underact. Muscles are paired, so every muscular action is a double effect. Failure of normal cooperation and even conflict between coupled muscles is a common idiopathic disorder. Internecine conflict between paired muscles leads to rupture, dislocations and extravasations. Depending on its nature, dislocated matter can initiate various problems, micro-organisms make infections, cells make neoplasms, etc.
Collapse
|
11
|
Capodicasa E, De Bellis F, Pelli MA. Effect of lansoprazole on human leukocyte function. Immunopharmacol Immunotoxicol 1999; 21:357-77. [PMID: 10319286 DOI: 10.3109/08923979909052768] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/13/2023]
Abstract
Recent findings on the capacity of omeprazole to influence various leukocyte functions, in vitro, raises the question on the potential use of protonic pump inhibitors, commonly used in the treatment of acid-secretion-related disorders, as immunomodulators. The aim of this study was to evaluate the in vitro effect of lansoprazole on human natural killer (NK) cell cytotoxix activity, chemotaxis and superoxide anion (O2*-) generation exerted by polymorphonucleated cells (PMNs). NK cytotoxicity activity was assessed by a 51Cr release assay, PMN chemotaxis was determined by an under agarose method and O2*- generation was analyzed on the basis of reduced cytochrome C. Incubation times with lansoprazole was 30 min for PMNs and 1-4.5 hours for NK cells, respectively. Lansoprazole induced significant dose dependent inhibition of NK cell activity and PMN functions at concentrations ranging from 100 to 1,000 microM. This study demonstrate that lansoprazole, like omeprazole, inhibits several leukocyte functions, in vitro, then suggesting that protonic pump inhibitors are able to provoke these effects, at least at certain doses.
Collapse
Affiliation(s)
- E Capodicasa
- Institute of Internal Medicine and Oncological Sciences, Perugia University, Italy
| | | | | |
Collapse
|
12
|
Abstract
OBJECTIVE Current literature was reviewed analyzing the outcome of peptic ulcer healing in relation to the results of the posttherapeutic Helicobacter pylori (HP) status. METHODS Literature was reviewed along with an analysis of 60 studies, comprising a total of 4329 patients. RESULTS Successful Helicobacter pylori eradication was found to induce a better response in peptic ulcer healing, regardless of diagnosis: gastric ulcer 88% vs 73% (odds ratio [OR] 2.7, p < 0.01), duodenal ulcer 95% vs 76% (OR 5.6, p < 0.0001), and peptic ulcer 95% vs 76% (OR 6.6, p < 0.0001), for patients having their HP infection successfully cured versus those remaining HP-positive, respectively (Fisher's exact test). For all evaluated time points (< or = 6, 7-8, and 10-12 wk after beginning treatment), HP-negative patients had higher healing rates than HP-positive patients (95% vs 82%, 94% vs 69%, and 96% vs 78% with corresponding OR of 4.2, 6.5, and 7.4, all p < 0.0001, Fisher's exact test). The use of concomitant acid suppression therapy during initial HP eradication provided a benefit on peptic ulcer healing only for patients with persistent HP infection (improved healing rates of 78% vs 67%; otherwise rates were 94-96%). Likewise, prolonged acid inhibition in HP treatment failures after the initial HP treatment phase resulted in 7-20% improved healing rates, whereas patients becoming HP-negative did not profit. CONCLUSION Successful HP eradication therapy accelerates peptic ulcer healing even without concomitant acid suppression.
Collapse
Affiliation(s)
- G Treiber
- Department of Gastroenterology, Robert-Bosch Hospital, Stuttgart, Germany
| | | |
Collapse
|
13
|
Gościniak G. IgG and IgA antibodies in Helicobacter pylori infections. ZENTRALBLATT FUR BAKTERIOLOGIE : INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY 1997; 286:494-502. [PMID: 9440198 DOI: 10.1016/s0934-8840(97)80052-7] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/05/2023]
Abstract
We compared Helicobacter pylori-specific IgG and IgA antibodies in serum, salivary and gastric juice of H. pylori-infected and noninfected patients using the ELISA method. Serum and salivary anti-H. pylori IgG and IgA titres were higher in H. pylori-positive than H. pylori-negative patients. Serum H. pylori IgG titres were higher than those of serum-specific IgA. In contrast, H. pylori IgA titres in saliva samples were higher than those of specific IgG. In all patients, the levels of IgG antibodies were very low in gastric juice. H. pylori-positive patients with increased levels of IgA in sera, also exhibited increased IgA levels in gastric juice. The determination of IgA antibodies in serum and saliva may be used as a test that complements the IgG antibody assay.
Collapse
Affiliation(s)
- G Gościniak
- Department of Microbiology University of Medicine, Wrocław, Poland
| |
Collapse
|
14
|
Gottrand F, Cullu F, Turck D, Vincent P, Michaud L, Husson MO, Martin-Delasalle E, Farriaux JP. Normal gastric histology in Helicobacter pylori-infected children. J Pediatr Gastroenterol Nutr 1997; 25:74-8. [PMID: 9226531 DOI: 10.1097/00005176-199707000-00012] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
BACKGROUND In adults, Helicobacter pylori infection is always associated with gastritis or ulcer. However, very active gastritis and ulcers are rarely seen in children. The aim of the present work was to study the relationships between H. pylori and gastric mucosa in children. METHODS Eighty infected children and adolescents including 48 (60%) neurologically impaired institutionalized patients, aged 2 months-22 years (mean 11.7 +/- 5.2 years) were studied retrospectively. All the patients underwent gastroscopy, and three antral and two fundic biopsy specimens were taken for histology and bacteriology. RESULTS A normal gastric mucosa was found in 22 of 80 patients (27.5%), whereas the others had gastritis (n = 58, 72.5%). There were no statistical differences between patients with normal histology and those presenting with gastritis for age, sex, ethnic background, symptoms, and the degree of bacterial colonization. The macroscopic aspect of gastritis was less frequently found in children with a normal histology compared with those with histological gastritis (p < 0.001). CONCLUSIONS These data show that H. pylori infection can be associated with a normal gastric histology in children.
Collapse
Affiliation(s)
- F Gottrand
- Service de Pédiatrie, Hôpital Huriez, Lille, France
| | | | | | | | | | | | | | | |
Collapse
|
15
|
Affiliation(s)
- B Seifrit
- Holy Spirit Hospital, Camp Hill, Pa, USA
| |
Collapse
|
16
|
|
17
|
Affiliation(s)
- M Crespi
- Regina Elena National Cancer Institute Service of Environmental Oncogenesis, Epidemiology, and Prevention, Rome, Italy
| | | |
Collapse
|
18
|
|
19
|
Affiliation(s)
- B Bourke
- Department of Pediatrics, University of Toronto, Ontario, Canada
| | | | | |
Collapse
|